When a Seizure Strikes, Are Your Patients Prepared?

A complete Seizure Preparedness Plan can help your patients live life with less fear and uncertainty. Download a plan now.

Valeant-Sponsored Programs

Valeant Pharmaceuticals is committed to helping patients with epilepsy/seizure disorders live life more fully, with greater peace of mind and confidence.

Epilepsy.com
New Seizure Planning Tools
Valeant Pharmaceuticals North America is proud to announce it recently provided Epilepsy.com with an unrestricted educational grant to create new, interactive Seizure Preparedness Planning tools.

EpilepsyFoundation.org
Camp Scholarship Program
Valeant Pharmaceuticals North America is teaming up with the Epilepsy Foundation to sponsor a Camper Scholarship Fund. Last year, the Fund assisted 64 campers in attending 16 Epilepsy Foundation camps around the country. More info and a directory of camps by state available in the March/April Issue of Epilepsy USA.

PBS Special: Epilepsy Defined
Public broadcasting stations across the U.S. are now airing a series of documentaries about epilepsy, including the Valeant -sponsored program Epilepsy Defined. View program descriptions, local stations and show times at www.itvisus.com.
 
IMPORTANT SAFETY INFORMATION

DIASTAT® AcuDial™ (diazepam rectal gel) is a gel formulation of diazepam intended for rectal administration in the management of selected, refractory patients with epilepsy, on stable regimens of AEDs, who require intermittent use of diazepam to control bouts of increased seizure activity for patients 2 years and older.

In clinical trials with DIASTAT®, the most frequent side effect was somnolence (23%). Less frequent adverse events reported were dizziness, headache, pain, vasodilation, diarrhea, ataxia, euphoria, incoordination, asthma, rash, abdominal pain, nervousness and rhinitis (1%-5%). Please see full DIASTAT AcuDial Prescribing Information.